|Dr Paul Liknaitzky|
Paul is a Research Fellow and Principal Investigator across a number of Australia’s first clinical psychedelic trials. He has established Australia’s first clinical psychedelic lab, leads the country’s largest clinical psychedelic trial and first applied therapist training programs, and has obtained the first industry funding and partnership for psychedelics in Australia. He collaborates widely in Australia and with international experts in psychedelic science and medicine.
|Prof Murat Yücel|
Murat is a clinical neuropsychologist who heads the Addiction and Mental Health research program at Monash, working at the interface between clinical neuropsychology, psychiatry, neuroscience and technology. He is the founding Director of BrainPark, and Co-Investigator within the Clinical Psychedelic Research Lab.
|Prof Suresh Sundram|
Suresh is a psychiatrist who heads the Translational Molecular Psychiatry and the Asylum Seeker and Refugee Mental Health research groups at Monash. He is Head of the Department of Psychiatry, and Co-Investigator within the Clinical Psychedelic Research Lab.
Rachel has worked in mental health and harm reduction, and is a Research Officer within the Clinical Psychedelic Research Lab. She is particularly interested in inflammatory-related biomarkers in mental illness.
Josh has worked in a range of academic and commercial research settings, and is a Research Officer within the Clinical Psychedelic Research Lab. He is particularly interested in psychedelics, mindfulness, psychological flexibility/rigidity and spontaneous brain activity.
Lead Psychotherapist and Trainer
Sean O’Carroll is the founder of Wild Mind, a private psychotherapy practice specialising in psychotherapy and training. Sean has developed psychotherapy training programs, and has interests in ecopsychology and psychedelic medicine. He develops and delivers psychedelic therapist training, provides ongoing supervision and support of the Lab's therapist teams, and is a trial therapist across a number of Australia's first psychedelic trials.
Psychotherapist and Trainer
Sarah is the Founding Director of Being Found, which provides personal and professional development, training, leadership, wellbeing, psychotherapy and coaching services. Sarah works with a unique blend of Ecopsychology, systems thinking and Process Work. She is a faculty member of the Metavision Institute and the Global Coaching Institute. Sarah is a trial therapist on one of Australia’s first psychedelic trails and works within the Psychedelic Psychotherapy and Training Team at the Clinical Psychedelic Research Lab.
|Prof James Bennett-Levy|
James is Professor in Mental Health and Psychological Wellbeing at the University of Sydney's University Centre for Rural Health. He is an internationally recognised leader in the field of psychotherapist training and research. James works within the Psychedelic Psychotherapy and Training Team at the Clinical Psychedelic Research Lab.
|A/Prof. Adrian Carter|
Adrian is an international leader in neuroethics and the responsible research and innovation of neurotechnology. He is Director, Community Engagement and Neuroethics at the Turner Institute at Monash and Director of Neuroethics Program for the ARC Centre of Excellence for Integrative Brain Function. Adrian collaborates within the Psychedelic Qualitative Team at the Clinical Psychedelic Research Lab.
|Dr Chris Letheby|
Dr Chris is a philosopher of mind and cognitive science, working on issues arising from the use of psychedelic drugs in psychiatry and neuroscience. He currently holds positions at the University of Western Australia and the University of Adelaide. Chris collaborates within the Psychedelic Psychometrics Team at the Clinical Psychedelic Research Lab.
Prof Jakob Hohwy
Jakob is the Founding Director of the new Monash Centre for Consciousness & Contemplative Studies, and Head of the Cognition & Philosophy Lab at Monash. He conducts interdisciplinary research in the areas of philosophy, psychology, and neuroscience, and is a leading figure in the influential field of Active Inference research. Jakob and his team explore the science of consciousness, decision-making, and theoretical neurobiology and psychiatry.
|Dr John Gardner|
John is a sociologist and scholar of science and technology studies. His research examines social and ethical dimensions of innovations in technology and medicine. John collaborates within the Psychedelic Qualitative Team at the Clinical Psychedelic Research Lab.
|Dr Jon Brett|
Jonathan is a staff specialist in clinical pharmacology, toxicology, and addiction medicine at St. Vincent's Hospital and a clinical toxicologist at NSW Poisons Information Centre. He is a conjoint A/Professor at St. Vincent's Clinical School at UNSW, is a senior NHRMC research fellow at the Centre for Big Data Research in Health at UNSW, and clinical pharmacology editor of the Internal Medicine Journal. His research interests lie in developing new treatments and models of care in addiction medicine.
|Dr Joshua Wiley|
Joshua is a behavioural medicine researcher with a strong interest in research methodology and statistics. His research examines the role of sleep dynamics in psychosocial factors and physical and mental health. Joshua collaborates with the Clinical Psychedelic Research Lab on research methodology and statistical analysis.
|A/Prof Kristian Rotaru|
Kristian is a decision scientist working at Monash Business School, BrainPark, and Brain, Mind and Markets Lab (UniMelb). His latest research focuses on risk analysis, affective decision making in everyday economic behaviours, neurocognitive and functional correlates of addiction, and on designing and testing interventions for behavioural change. Kristian collaborates with the Clinical Psychedelic Research Lab on risk assessment, mitigation, and control of the Psi-GAD-1 and MMP-1 trials.
|Dr Marg Ross|
Marg is a Senior Clinical Psychologist working in Psychosocial Cancer Care and Palliative Medicine at St Vincent’s Hospital in Melbourne, and is Chief Principal Investigator for Australia’s first psilocybin-assisted psychotherapy study. She is a Co-Investigator on the Psi-GAD-1 trial within the Clinical Psychedelic Research Lab, and involved in the development of psychedelic therapist training.
|Dr Rick Doblin|
Rick is the Founder and Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), the leading non-profit international psychedelic research and educational organisation. He received a Masters and PhD in Public Policy from Harvard's Kennedy School of Government, and has been a central figure in the re-emergence of clinical psychedelic research over the past 35 years. Rick collaborates with the Clinical Psychedelic Lab on MDMA-assisted therapy research and training development.
|Dr Vince Polito|
Vince is a Senior Research Fellow in the Department of Cognitive Science at Macquarie. His research focuses on agency, self-representation, hypnosis, and psychedelics. He led one of the first systematic studies on microdosing psychedelics, and is conducting further microdosing trials. Vince collaborates within the Psychedelic Psychometrics Team at the Clinical Psychedelic Research Lab.
International therapist trainers and mentors